F42
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: written informed consent age 18-70 primary diagnosis of OCD (ICD-10 F42.-) at least 20 sessions of CBT with ERP within 3 years prior to study inclusion clinically relevant OCD, i.e. Y-BOCS global score > 12 at study inclusion fulfilled DSM-IV criteria for OCD for a period of = three years prior to study inclusion, either without an aymptomatic period or an asymptomatic period of < 6 months
Exclusion criteria
Exclusion criteria: begun or altered medication within 12 weeks before study inclusion receiving benzodiazepines mania (ICD-10 F30.-) suicidal tendency current severe depressive episode (BDI>28) borderline disorder (ICD-10 F60.3) current substance abuse or substance dependence (ICD-10 F1x.2) intelligence quotient < 70 psychosis (ICD-10 F20-F29) severe neurological disorder indication of Asperger syndrome (ICD-10 F84.5)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the severity of obsessive compulsive symptoms as measured by the Yale Brown Obsessive Compulsive Scale, an established and very commonly used semi-structured interview. Assesment time points are pre, post and 6- and 12-months-follow-ups | — |
Secondary
| Measure | Time frame |
|---|---|
| - depression (Beck Depression Inventory) - global level of psychopathology (Brief Symptom Inventory) - quality of life (World Health Organization Quality of Life abbreviated) - mindfulness (Kentucky Inventory of Mindfulness Skills) - metacognitions (Obsessive Belief Questionnaire, Metacognitions Questionnaire) - psychological flexibility/experiential avoidance (Acceptance and Action Questionnaire) Assesment time points are pre, post and 6- and 12-months-follow-ups | — |
Countries
Germany
Contacts
Universitätsklinikum Freiburg, Abteilung für Psychiatrie und Psychotherapie